Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice

Journal of Autoimmunity

Volumn 42, Issue , 2013, Pages 71-79

  Freeman, Michael L ^a   Burkum, Claire E ^a   Lanzer, Kathleen G ^a   Roberts, Alan D ^a   Pinkevych, Mykola ^b   Itakura, Asako ^c   Kummer, Lawrence W ^a   Szaba, Frank M ^a   Davenport, Miles P ^b   McCarty, Owen J T ^c   Woodland, David L ^a   Smiley, Stephen T ^a   Blackman, Marcia A ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gammaherpesvirus; Thrombocytopenia; Viral latency

Indexed keywords

THROMBOCYTE ANTIBODY; WARFARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS 68; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIA; VIRUS LATENCY; VIRUS REPLICATION;

ANIMALS; ANTIBODIES; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN MU-CHAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPECIES SPECIFICITY; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84877122675     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.11.005     Document Type: Article

References (67)

1. Rickinson A.B., Kieff E. Epstein-barr virus. Fields virology 2001, 2575-2627. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
2. Doherty P.C., Christensen J.P., Belz G.T., Stevenson P.G., Sangster M.Y. Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001, 356:581-593.
3. Niller H.H., Wolf H., Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008, 41:298-328.
4. Jenson H.B. Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr 2000, 12:263-268.
5. Kimura H., Morishima T., Kanegane H., Ohga S., Hoshino Y., Maeda A., et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003, 187:527-533.
6. Cines D.B., Liebman H.A. The immune thrombocytopenia syndrome: a disorder of diverse pathogenesis and clinical presentation. Hematol Oncol Clin North Am 2009, 23:1155-1161.
7. Stasi R., Willis F., Shannon M.S., Gordon-Smith E.C. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am 2009, 23:1275-1297.
8. Flaujac C., Boukour S., Cramer-Borde E. Platelets and viruses: an ambivalent relationship. Cell Mol Life Sci 2010, 67:545-556.
9. Tanaka M., Kamijo T., Koike K., Ueno I., Nakazawa Y., Kurokawa Y., et al. Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia. Int J Hematol 2003, 78:168-170.
10. Pipp M.L., Means N.D., Sixbey J.W., Morris K.L., Gue C.L., Baddour L.M. Acute Epstein-Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis 1997, 25:1237-1239.
11. Virgin H.W., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., et al. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 1997, 71:5894-5904.
12. Efstathiou S., Ho Y.M., Hall S., Styles C.J., Scott S.D., Gompels U.A. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol 1990, 71(Pt 6):1365-1372.
13. Blackman M.A., Flano E. Persistent gamma-herpesvirus infections: what can we learn from an experimental mouse model?. J Exp Med 2002, 195:F29-F32.
14. Flano E., Husain S.M., Sample J.T., Woodland D.L., Blackman M.A. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 2000, 165:1074-1081.
15. Flano E., Jia Q., Moore J., Woodland D.L., Sun R., Blackman M.A. Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol 2005, 174:4972-4978.
16. Tripp R.A., Hamilton-Easton A.M., Cardin R.D., Nguyen P., Behm F.G., Woodland D.L., et al. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?. J Exp Med 1997, 185:1641-1650.
17. Coppola M.A., Flano E., Nguyen P., Hardy C.L., Cardin R.D., Shastri N., et al. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection. J Immunol 1999, 163:1481-1489.
18. Hardy C.L., Flano E., Cardin R.D., Kim I.J., Nguyen P., King S., et al. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine gamma-herpesvirus infection. Viral Immunol 2001, 14:391-402.
19. Peacock J.W., Elsawa S.F., Petty C.C., Hickey W.F., Bost K.L. Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. Eur J Immunol 2003, 33:1849-1858.
20. Casiraghi C., Shanina I., Cho S., Freeman M.L., Blackman M.A., Horwitz M.S. Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis. PLoS Pathog 2012, 8:e1002715.
21. Nelson D.A., Petty C.C., Bost K.L. Infection with murine gammaherpesvirus 68 exacerbates inflammatory bowel disease in IL-10-deficient mice. Inflamm Res 2009, 58:881-889.
22. Sangster M.Y., Topham D.J., D'Costa S., Cardin R.D., Marion T.N., Myers L.K., et al. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 2000, 164:1820-1828.
23. Larson J.D., Thurman J.M., Rubtsov A.V., Claypool D., Marrack P., van Dyk L.F., et al. Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity. Proc Natl Acad Sci U S A 2012, 109:E1092-E1100.
24. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007, 447:326-329.
25. Yager E.J., Szaba F.M., Kummer L.W., Lanzer K.G., Burkum C.E., Smiley S.T., et al. gamma-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol 2009, 22:67-72.
26. -/- mice are agammaglobulinemic and fail to maintain B220-CD138+ plasma cells. J Immunol 2007, 178:2192-2203.
27. Carragher D.M., Kaminski D.A., Moquin A., Hartson L., Randall T.D. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol 2008, 181:4168-4176.
28. Jia Q., Freeman M.L., Yager E.J., McHardy I., Tong L., Martinez-Guzman D., et al. Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency. J Virol 2010, 84:2453-2465.
29. Usherwood E.J., Ward K.A., Blackman M.A., Stewart J.P., Woodland D.L. Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 2001, 75:8283-8288.
30. Johnson L.L., Berggren K.N., Szaba F.M., Chen W., Smiley S.T. Fibrin-mediated protection against infection-stimulated immunopathology. J Exp Med 2003, 197:801-806.
31. Mullarky I.K., Szaba F.M., Berggren K.N., Parent M.A., Kummer L.W., Chen W., et al. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect Immun 2005, 73:3888-3895.
32. Dowling M.R., Milutinovic D., Hodgkin P.D. Modelling cell lifespan and proliferation: is likelihood to die or to divide independent of age?. J R Soc Interface 2005, 2:517-526.
33. Dowling M.R., Josefsson E.C., Henley K.J., Hodgkin P.D., Kile B.T. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood 2010, 116:1776-1778.
34. Itakura A., Aslan J.E., Sinha S., White-Adams T.C., Patel I.A., Meza-Romero R., et al. Characterization of human platelet binding of recombinant T cell receptor ligand. J Neuroinflammation 2010, 7:75.
35. Huang K.J., Li S.Y., Chen S.C., Liu H.S., Lin Y.S., Yeh T.M., et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 2000, 81:2177-2182.
36. Cardin R.D., Brooks J.W., Sarawar S.R., Doherty P.C. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 1996, 184:863-871.
37. Nunez D., Charriaut-Marlangue C., Barel M., Benveniste J., Frade R. Activation of human platelets through gp140, the C3d/EBV receptor (CR2). Eur J Immunol 1987, 17:515-520.
38. Kinoshita T., Takeda J., Hong K., Kozono H., Sakai H., Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol 1988, 140:3066-3072.
39. Freeman M.L., Burkum C.E., Woodland D.L., Sun R., Wu T.T., Blackman M.A. Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine gamma-herpesvirus-68. J Immunol 2012, 188:1049-1056.
40. Sandler S.G. The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura. Semin Hematol 2000, 37:10-12.
41. Stapler D., Lee E.D., Selvaraj S.A., Evans A.G., Kean L.S., Speck S.H., et al. Expansion of effector memory TCR Vbeta4+ CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance. J Immunol 2008, 180:3190-3200.
42. Evans A.G., Moser J.M., Krug L.T., Pozharskaya V., Mora A.L., Speck S.H. A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J Exp Med 2008, 205:669-684.
43. Ebrahimi B., Dutia B.M., Brownstein D.G., Nash A.A. Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am J Pathol 2001, 158:2117-2125.
44. Stewart J.P., Usherwood E.J., Ross A., Dyson H., Nash T. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 1998, 187:1941-1951.
45. Freeman M.L., Lanzer K.G., Cookenham T., Peters B., Sidney J., Wu T.T., et al. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J Virol 2010, 84:2881-2892.
46. Winiarski J. Mechanisms in childhood idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998, 424:54-56.
47. Onan E., Uskudar O., Coskun Y., Akkiz H. Higher hepatis C virus concentration in platelets than in plasma in a patient with ITP. Platelets 2012, 23:413-414.
48. Cserti-Gazdewich C.M., Pendergrast J.M., Reis M. Postvaccination hyperhemolysis coinciding with remission of Epstein Barr virus (EBV)-associated immune thrombocytopenic purpura (ITP). Am J Hematol 2009, 84:612-613.
49. Bordin J.O., Smith J.W., Hayward C.P., Warkentin T.E., Wasi P., Kelton J.G. Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol 1995, 90:332-335.
50. Costello C. Virus infection-associated improvement of platelet counts in chronic ITP. Br J Haematol 1995, 91:517-518.
51. Proctor S.J., Reid M.M., Galloway M.J. Virus infection-associated improvement of platelet counts in chronic ITP. Br J Haematol 1995, 91:516-517.
52. Warkentin T.E. Heparin-induced thrombocytopenia: diagnosis and management. Circulation 2004, 110:e454-e458.
53. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
54. Semple J.W., Freedman J. Autoimmune pathogenesis and autoimmune hemolytic anemia. Semin Hematol 2005, 42:122-130.
55. Zoller E.E., Lykens J.E., Terrell C.E., Aliberti J., Filipovich A.H., Henson P.M., et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 2011, 208:1203-1214.
56. Sato K., Misawa N., Nie C., Satou Y., Iwakiri D., Matsuoka M., et al. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011, 117:5663-5673.
57. Clambey E.T., Virgin H.W., Speck S.H. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol 2000, 74:1973-1984.
58. Macrae A.I., Usherwood E.J., Husain S.M., Flano E., Kim I.J., Woodland D.L., et al. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol 2003, 77:9700-9709.
59. Herskowitz J.H., Jacoby M.A., Speck S.H. The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. J Virol 2005, 79:2261-2273.
60. Tarakanova V.L., Stanitsa E., Leonardo S.M., Bigley T.M., Gauld S.B. Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo. Virology 2010, 405:50-61.
61. Sunil-Chandra N.P., Efstathiou S., Nash A.A. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 1992, 73(Pt 12):3275-3279.
62. Flano E., Kim I.J., Woodland D.L., Blackman M.A. Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 2002, 196:1363-1372.
63. Liang X., Collins C.M., Mendel J.B., Iwakoshi N.N., Speck S.H. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog 2009, 5:e1000677.
64. Montes C.L., Acosta-Rodriguez E.V., Merino M.C., Bermejo D.A., Gruppi A. Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host?. J Leukoc Biol 2007, 82:1027-1032.
65. Godeau B., Michel M. Treatment of chronic immune thrombocytopenic purpura in adults. Ann Hematol 2010.
66. Samuelsson A., Towers T.L., Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001, 291:484-486.
67. Siragam V., Crow A.R., Brinc D., Song S., Freedman J., Lazarus A.H. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med 2006, 12:688-692.